[{"id":"d5f16fca-a36a-46b1-8c00-c70acf825591","acronym":"PRIMUS","url":"https://clinicaltrials.gov/study/NCT04247217","created_at":"2021-01-18T20:38:37.828Z","updated_at":"2024-07-02T16:36:09.862Z","phase":"","brief_title":"Immune Profiling After HDR in Local Relapsed Prostate Cancer","source_id_and_acronym":"NCT04247217 - PRIMUS","lead_sponsor":"Maastricht Radiation Oncology","biomarkers":" CXCL12 • IL23A","pipe":" | ","alterations":" CXCL12 expression","tags":["CXCL12 • IL23A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CXCL12 expression"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 02/19/2020","start_date":" 02/19/2020","primary_txt":" Primary completion: 12/23/2021","primary_completion_date":" 12/23/2021","study_txt":" Completion: 12/23/2021","study_completion_date":" 12/23/2021","last_update_posted":"2022-05-26"}]